BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34476338)

  • 21. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
    Bass AR; Chakravarty E; Akl EA; Bingham CO; Calabrese L; Cappelli LC; Johnson SR; Imundo LF; Winthrop KL; Arasaratnam RJ; Baden LR; Berard R; Bridges SL; Cheah JTL; Curtis JR; Ferguson PJ; Hakkarinen I; Onel KB; Schultz G; Sivaraman V; Smith BJ; Sparks JA; Vogel TP; Williams EA; Calabrese C; Cunha JS; Fontanarosa J; Gillispie-Taylor MC; Gkrouzman E; Iyer P; Lakin KS; Legge A; Lo MS; Lockwood MM; Sadun RE; Singh N; Sullivan N; Tam H; Turgunbaev M; Turner AS; Reston J
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):449-464. PubMed ID: 36597813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel Disease.
    Pittet LF; Verolet CM; Michetti P; Gaillard E; Girardin M; Juillerat P; Mottet C; Maillard MH; Siegrist CA; Posfay-Barbe KM;
    Digestion; 2021; 102(6):956-964. PubMed ID: 33971650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Vaccinating the Patient With Inflammatory Bowel Disease.
    Coukos J; Farraye FA
    Curr Treat Options Gastroenterol; 2018 Dec; 16(4):548-560. PubMed ID: 30293209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization history of children with inflammatory bowel disease.
    Soon IS; deBruyn JC; Wrobel I
    Can J Gastroenterol; 2013 Apr; 27(4):213-6. PubMed ID: 23616959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants.
    Chiarella-Redfern H; Lee S; Jubran B; Sharifi N; Panaccione R; Constantinescu C; Benchimol EI; Seow CH
    Inflamm Bowel Dis; 2022 Jan; 28(1):79-86. PubMed ID: 33609034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
    Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S
    J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000.
    Halsey NA; Hyman SL;
    Pediatrics; 2001 May; 107(5):E84. PubMed ID: 11331734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination strategies in pediatric inflammatory bowel disease.
    Dipasquale V; Romano C
    Vaccine; 2017 Oct; 35(45):6070-6075. PubMed ID: 28967524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
    Uziel Y; Moshe V; Onozo B; Kulcsár A; Tróbert-Sipos D; Akikusa JD; Salviato Pileggi G; Maritsi D; Kasapcopur O; Rodrigues M; Smerla R; Rigante D; Makay B; Atsali E; Wulffraat N; Toplak N;
    Vaccine; 2020 Feb; 38(9):2198-2201. PubMed ID: 31987692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
    Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.
    Jansen MH; Rondaan C; Legger G; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg M; Berbers G; Bruijning P; Egert Y; Normand C; Bijl M; Foster H; Kone-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
    Front Pediatr; 2022; 10():910026. PubMed ID: 35874582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for immunizations in patients with inflammatory bowel disease.
    Sands BE; Cuffari C; Katz J; Kugathasan S; Onken J; Vitek C; Orenstein W
    Inflamm Bowel Dis; 2004 Sep; 10(5):677-92. PubMed ID: 15472534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease.
    Marín AC; Gisbert JP; Chaparro M
    World J Gastroenterol; 2015 Oct; 21(40):11273-81. PubMed ID: 26527572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease.
    Xu F; deJong N; Kappelman MD; Greenlund KJ; Carlson SA
    Inflamm Bowel Dis; 2023 May; 29(5):726-734. PubMed ID: 35779060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.
    Mack DR; Benchimol EI; Critch J; deBruyn J; Tse F; Moayyedi P; Church P; Deslandres C; El-Matary W; Huynh H; Jantchou P; Lawrence S; Otley A; Sherlock M; Walters T; Kappelman MD; Sadowski D; Marshall JK; Griffiths A
    Gastroenterology; 2019 Aug; 157(2):320-348. PubMed ID: 31320109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccinations and Immunization Status in Pediatric Inflammatory Bowel Disease: A Multicenter Study From the Pediatric IBD Porto Group of the ESPGHAN.
    Martinelli M; Giugliano FP; Strisciuglio C; Urbonas V; Serban DE; Banaszkiewicz A; Assa A; Hojsak I; Lerchova T; Navas-López VM; Romano C; Sladek M; Veres G; Aloi M; Kucinskiene R; Miele E
    Inflamm Bowel Dis; 2020 Aug; 26(9):1407-1414. PubMed ID: 31689349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021.
    Jansen MHA; Rondaan C; Legger GE; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg L; Berbers GAM; Bruijning P; Egert Y; Normand C; Bijl M; Foster HE; Koné-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
    Ann Rheum Dis; 2023 Jan; 82(1):35-47. PubMed ID: 35725297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.